Male contraception properties of a new synthetic steroid derivative (danazol) in Rattus rattus rufescens.
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Chronic danazol administration in rats caused testicular lesions, reduced sperm counts, impaired Leydig cell function, inhibited nucleic acid and protein synthesis, and altered cholesterol and enzyme levels, reversibly inhibiting spermatogenesis and steroidogenesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Chronic administration of Danazol (25 mg/kg body wt) caused lesions in the testes of Rattus rattus Rufescens. Depletion of spermatocytes, spermatids and spermatozoa was conspicuous. Impairment of Leydig cell function was correlated with reduced cell size and depressed accessory sex organ weights. Epididymal cell height was greatly reduced. The lumen was devoid of spermatozoa. Danazol administration inhibited the synthesis of RNA, protein, sialic acid in the testes and accessory sex organs. Total cholesterol of the testes was increased, whereas the acid phosphatase enzyme activity was reduced. Testosterone propionate did not enhance the growth of accessory sex organs in castrated rats receiving Danazol. In conclusion, Danazol inhibits the system of steroidogenesis and spermatogenesis in Rattus rattus, when treated chronically for a period of 40 days. These effects are reversible after 60 days of cessation of drug administration.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (39)
- doi:10.1097/bpb.0000000000000117 via openalex
- doi:10.1089/biores.2015.0009 via openalex
- doi:10.1056/nejmoa012604 via openalex
- doi:10.1016/j.biomaterials.2010.06.039 via openalex
- doi:10.1242/dev.064162 via openalex
- doi:10.1111/j.1600-0765.2011.01428.x via openalex
- doi:10.1016/j.biomaterials.2007.09.014 via openalex
- doi:10.1016/j.biomaterials.2016.07.020 via openalex
- doi:10.1002/jcp.22639 via openalex
- doi:10.1016/j.jss.2011.11.1029 via openalex
- doi:10.1126/scitranslmed.3008085 via openalex
- doi:10.1016/j.yexcr.2010.05.035 via openalex
- doi:10.1089/ten.tea.2011.0024 via openalex
- doi:10.1002/jcb.1259 via openalex
- doi:10.1007/s00441-014-2006-6 via openalex
- doi:10.1016/j.biomaterials.2013.01.061 via openalex
- doi:10.1016/j.biomaterials.2015.07.040 via openalex
- doi:10.1038/nbt1109 via openalex
- doi:10.1089/biores.2012.0271 via openalex
- doi:10.1016/j.biomaterials.2008.11.040 via openalex
- doi:10.1615/critreveukaryotgeneexpr.v13.i24.130 via openalex
- doi:10.1089/ten.tea.2009.0826 via openalex
- doi:10.1152/ajpcell.00565.2004 via openalex
- doi:10.1074/jbc.m008539200 via openalex
- doi:10.1002/jbm.b.33166 via openalex
- doi:10.3928/01477447-20100526-24 via openalex
- doi:10.1152/ajpcell.00189.2013 via openalex
- doi:10.3389/fimmu.2014.00510 via openalex
- doi:10.1089/ten.tea.2012.0475 via openalex
- doi:10.2106/jbjs.f.01350 via openalex
- doi:10.1002/jcp.20841 via openalex
- doi:10.1007/s12195-012-0221-3 via openalex
- doi:10.5435/00124635-201102001-00007 via openalex
- doi:10.1089/ten.tea.2010.0169 via openalex
- doi:10.1016/j.biomaterials.2012.02.034 via openalex
- doi:10.1615/critreveukaryotgeneexpr.v13.i24.180 via openalex
- doi:10.1089/ten.tea.2010.0682 via openalex
- doi:10.2152/jmi.54.248 via openalex
- doi:10.1097/phm.0000000000000145 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T04:18:53.007311+00:00
License: CC0
· commercial use OK